Chemoinformaics analysis of 4-(ALPHA-RHAMNOPYRANOSYL)ELLAGIC ACID
Molecular Weight | 448.336 | nRot | 2 |
Heavy Atom Molecular Weight | 432.208 | nRig | 27 |
Exact Molecular Weight | 448.064 | nRing | 5 |
Solubility: LogS | -4.186 | nHRing | 3 |
Solubility: LogP | -0.33 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 4 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
nHetero | 12 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 12 | No. of Arom Bond | 19 |
nHA | 12 | APOL | 53.6927 |
nHD | 6 | BPOL | 24.7313 |
QED | 0.134 |
Synth | 4.328 |
Natural Product Likeliness | 1.989 |
NR-PPAR-gamma | 0.886 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.996 |
HIA | 0.826 |
CACO-2 | -6.265 |
MDCK | 0.0000251 |
BBB | 0.012 |
PPB | 0.73187 |
VDSS | 0.92 |
FU | 0.262304 |
CYP1A2-inh | 0.072 |
CYP1A2-sub | 0.114 |
CYP2c19-inh | 0.012 |
CYP2c19-sub | 0.06 |
CYP2c9-inh | 0.017 |
CYP2c9-sub | 0.216 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.137 |
CYP3a4-inh | 0.016 |
CYP3a4-sub | 0.007 |
CL | 2.152 |
T12 | 0.606 |
hERG | 0.004 |
Ames | 0.318 |
ROA | 0.045 |
SkinSen | 0.271 |
Carcinogencity | 0.199 |
EI | 0.017 |
Respiratory | 0.029 |
NR-Aromatase | 0.773 |
Antiviral | Yes |
Prediction | 0.711019 |